热门资讯> 正文

Altimune将加入纳斯达克生物技术指数

2024-12-19 20:38

Altimmune(ALT) 0

Altimmune (NASDAQ:ALT) has announced that it will be added to the Nasdaq Biotechnology Index, effective prior to the market open on Monday, December 23, 2024.
Source: Press Release

More on Altimmune

Altimmune 2025: Redefining Obesity And MASH Treatment
Altimmune: Pemvidutide As MASH Drug Could Provide Competitive Edge
Altimmune's Pemvidutide Gains Momentum: Sizeable TAMs In Obesity And Liver Health
Altimmune stock rallies 30% on business updates, UBS buy rating
Altimmune Q3 2024 Earnings Preview

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。